Scharf Matthew T
Sleep Center, Division of Pulmonary and Critical Care, Department of Medicine and Department of Neurology, Rutgers- Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Nat Sci Sleep. 2022 Dec 13;14:2151-2156. doi: 10.2147/NSS.S340950. eCollection 2022.
The Epworth sleepiness scale (ESS) is a commonly used questionnaire to evaluate patients for excessive daytime sleepiness (EDS). The ESS has been validated as a measure of EDS, but a number of studies have shown more test-retest variability in clinical settings compared to the original validation study. This observation of higher-than-expected test-retest variability has called into question the utility of the ESS as a clinical tool to assess EDS. The purpose of this review article is to summarize how studies of test-retest variability in clinical populations compare to the original validation study of Johns and to highlight where they differ. Furthermore, use of the ESS as a continuous variable (with no specified cutoff value) versus a categorical variable (normal versus high) is described. These observations are put into a clinical context by comparing the test-retest variability observed on the ESS with that of the multiple sleep latency test (MSLT). Finally, how contributors to ESS scores differ within certain subpopulations is described. The ESS remains an important tool to measure EDS in patient populations, but an awareness of its limitations needs to be considered.
爱泼沃斯嗜睡量表(ESS)是一种常用的问卷,用于评估患者白天过度嗜睡(EDS)的情况。ESS已被确认为一种衡量EDS的方法,但与最初的验证研究相比,许多研究表明在临床环境中其重测变异性更大。这种高于预期的重测变异性的观察结果对ESS作为评估EDS的临床工具的效用提出了质疑。这篇综述文章的目的是总结临床人群中重测变异性的研究与约翰斯最初的验证研究相比情况如何,并突出它们的不同之处。此外,还描述了将ESS用作连续变量(无指定临界值)与分类变量(正常与高)的情况。通过将ESS上观察到的重测变异性与多次睡眠潜伏期试验(MSLT)的重测变异性进行比较,将这些观察结果置于临床背景中。最后,描述了在某些亚组中ESS评分的影响因素如何不同。ESS仍然是测量患者群体中EDS的重要工具,但需要考虑其局限性。